
Sanofi SNY
$ 44.06
0.18%
Annual report 2025
added 03-14-2026
Sanofi Cash Conversion Cycle 2011-2026 | SNY
Annual Cash Conversion Cycle Sanofi
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 184 | 183 | 193 | 208 | 202 | 180 |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 208 | 180 | 192 |
Cash Conversion Cycle of other stocks in the Biotechnology industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AbCellera Biologics
ABCL
|
173 | $ 3.55 | -0.28 % | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
117 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adagene
ADAG
|
53.8 | $ 3.91 | -2.01 % | $ 220 M | ||
|
Advaxis
ADXS
|
-143 K | - | -9.65 % | $ 45.9 M | ||
|
I-Mab
IMAB
|
-1.97 K | - | - | $ 866 M | ||
|
AgeX Therapeutics
AGE
|
-8.96 K | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
-1.55 K | - | -0.23 % | $ 916 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
17 | - | -1.52 % | $ 24.7 M | ||
|
Aptorum Group Limited
APM
|
-400 | $ 0.79 | 0.04 % | $ 4.31 M | ||
|
Midatech Pharma plc
MTP
|
82.8 | - | -18.52 % | $ 27.3 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 6.39 | -3.62 % | $ 175 M | ||
|
BioCardia
BCDA
|
101 | $ 1.28 | 0.79 % | $ 27.1 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Catalyst Biosciences
CBIO
|
71.5 | $ 11.1 | -4.15 % | $ 992 M | ||
|
Aeterna Zentaris
AEZS
|
-34.3 K | - | 5.93 % | $ 314 M | ||
|
Anika Therapeutics
ANIK
|
270 | $ 14.51 | 1.04 % | $ 213 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-123 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.15 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
174 | $ 2.59 | -1.89 % | $ 16.3 M |